Cargando…

Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation

Pristimerin, a quinonemethide triterpenoid, has demonstrated anticancer activity against a number of types of cancer, including breast cancer. However, its mechanism of action remains unclear. The present study investigated the autophagy-induced anticancer efficacy of pristimerin on MDA-MB-231 human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Younju, Na, Jinuk, Lee, Myung Sun, Cha, Eun Young, Sul, Ji Young, Park, Jun Beom, Lee, Jin Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172393/ https://www.ncbi.nlm.nih.gov/pubmed/30221728 http://dx.doi.org/10.3892/mmr.2018.9488

Ejemplares similares

A natural ent-kaurane diterpenoid induces antiproliferation in ovarian cancer cells via ERK1/2 regulation and inhibition of cellular migration and invasion
por: Lee, Jin Sun, et al.
Publicado: (2018)

Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway
por: Lee, Jin Sun, et al.
Publicado: (2019)

Corosolic acid reduces 5-FU chemoresistance in human gastric cancer cells by activating AMPK
por: Park, Jun Beom, et al.
Publicado: (2018)

Antifungal Activity of Maytenin and Pristimerin
por: Gullo, Fernanda P., et al.
Publicado: (2012)

Pristimerin, a triterpene that inhibits monoacylglycerol lipase activity, prevents the development of paclitaxel-induced allodynia in mice
por: Al-Romaiyan, Altaf, et al.
Publicado: (2022)

Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy
por: Chen, Chao, et al.
Publicado: (2022)

A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells
por: Huang, Peng, et al.
Publicado: (2019)

Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
por: Chen, Run-Ze, et al.
Publicado: (2021)

Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis
por: Lee, Kyung Ha, et al.
Publicado: (2017)

Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
por: Li, Jia-jun, et al.
Publicado: (2019)

Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells
por: Lee, Seon-Ok, et al.
Publicado: (2016)

Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo
por: Zhao, Qun, et al.
Publicado: (2019)

Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation
por: Mu, Xianmin, et al.
Publicado: (2012)

Piperlongumine induces apoptosis via the MAPK pathway and ERK-mediated autophagy in human melanoma cells
por: Jeon, Su-Ji, et al.
Publicado: (2023)

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
por: Qi, Dahu, et al.
Publicado: (2021)

Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo
por: Mori, Yuki, et al.
Publicado: (2017)

Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis
por: Cheng, Shihuan, et al.
Publicado: (2020)

Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells
por: Wang, Yongwei, et al.
Publicado: (2012)

Identification of P-Glycoprotein and Transport Mechanism of Paclitaxel in Syncytiotrophoblast Cells
por: Lee, Na-Young, et al.
Publicado: (2014)

Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
por: El-Agamy, Dina S., et al.
Publicado: (2018)

Magnolin Inhibits Paclitaxel-Induced Cold Allodynia and ERK1/2 Activation in Mice
por: Kim, Nari, et al.
Publicado: (2023)

Pristimerin enhances the effect of cisplatin by inhibiting the miR-23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells
por: Zhang, Yingbing, et al.
Publicado: (2019)

Mitochondrial ROS activates ERK/autophagy pathway as a protected mechanism against deoxypodophyllotoxin-induced apoptosis
por: Kim, Sang-Hun, et al.
Publicado: (2017)

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
por: Li, Xuedong, et al.
Publicado: (2021)

Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
por: Kim, Yoo-Na, et al.
Publicado: (2019)

Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo
por: Sun, Peng, et al.
Publicado: (2020)

Chrysin Induces Apoptosis via the MAPK Pathway and Regulates ERK/mTOR-Mediated Autophagy in MC-3 Cells
por: Jung, Gi-Hwan, et al.
Publicado: (2022)

Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 Lung Cancer Cells
por: Li, Jiajun, et al.
Publicado: (2020)

Dendropanoxide Induces Autophagy through ERK1/2 Activation in MG-63 Human Osteosarcoma Cells and Autophagy Inhibition Enhances Dendropanoxide-Induced Apoptosis
por: Lee, Ji-Won, et al.
Publicado: (2013)

Differences between Drug-Induced and Contrast Media-Induced Adverse Reactions Based on Spontaneously Reported Adverse Drug Reactions
por: Ryu, JiHyeon, et al.
Publicado: (2015)

Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin
por: LIU, YONG BO, et al.
Publicado: (2014)

Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells
por: DEEB, DORRAH, et al.
Publicado: (2015)

Lupeol and pristimerin do not inhibit activation of the human sperm CatSper Ca(2+)-channel
por: Rehfeld, Anders, et al.
Publicado: (2022)

Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis
por: Shu, Chang, et al.
Publicado: (2020)

Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro
por: Yan, Yan-Yan, et al.
Publicado: (2017)

Inhibition of ERK1/2 by silymarin in mouse mesangial cells
por: Youn, Cha Kyung, et al.
Publicado: (2017)

Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p
por: Li, Zaiyu, et al.
Publicado: (2019)

Chloroquine Combined with Imatinib Overcomes Imatinib Resistance in Gastrointestinal Stromal Tumors by Inhibiting Autophagy via the MAPK/ERK Pathway
por: Zheng, Song, et al.
Publicado: (2020)

Analgesic effects and metabolome analyses of laser- and electro-acupuncture combined therapies in paclitaxel-induced neuropathic pain model
por: Yoon, Chan-Suk, et al.
Publicado: (2023)

Combined Treatment of Murine Fibrosarcoma with Chemotherapy (Paclitaxel), Radiotherapy, and Intratumoral Injection of Dendritic Cells
por: Byun, Ji-Won, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5783v4rq57nq29r2u74qt5kdj7